9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer

Kuroki, H; Anraku, T; Kazama, A; Bilim, V; Tasaki, M; Schmitt, D; Mazar, AP; Giles, FJ; Ugolkov, A; Tomita, Y

Tomita, Y (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Urol, Mol Oncol, Niigata, Japan.

SCIENTIFIC REPORTS, 2019; 9 ():

Abstract

Glycogen synthase kinase-3 beta (GSK-3 beta), a serine/threonine kinase, has been identified as a potential therapeutic target in human bladder cancer......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索